Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176226 · ClinicalTrials.gov registry record · NA
IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT02176226 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 105 participants.
The verdict
NCT02176226, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study will evaluate a Smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for patients. The intervention, referred to as IntelliCare, delivers patient-specific treatment material and motivational messaging via a mobile phone, to help individuals with depression and/or anxiety. Information and data received from the patient will inform the tailored treatment approach through machine learning. The purpose of this study is to obtain preliminary information on the feasibility and effectiveness of IntelliCare in improving symptoms of depression and anxiety.
Interventions
- BEHAVIORAL IntelliCare
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02176226
The ClinicalTrials.gov registry entry for NCT02176226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IntelliCare is the first listed.
NCT02176226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02176226 about?
NCT02176226 is a clinical study titled "IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)". This study will evaluate a Smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for patients. The intervention, referred to as IntelliCare, delivers patient-specific treatment material and motivational messaging via a mobile phone, to help individuals wit...
What is the current status of trial NCT02176226?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2015-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02176226?
The interventions under investigation include: IntelliCare (BEHAVIORAL).
Who is sponsoring clinical trial NCT02176226?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.